Ravi Patel, Customer Admin

Customer profiles

How the Meridian Medical Systems profile resolves into 174 effective obligations for PRJ-2026-0042.

CFP-0001Effectivebase FR-2026.1

Effective obligations

174

against FR-2026.1

Resolution layers

6

core to exceptions

Profile additions

2

approved, additive

Active exceptions

1

EXC-0009 expires 31 Dec

Obligation composition

Effective obligations by resolution layer
SegmentCountShare
Core PSLF baseline14885%
Market profile148%
Customer profile85%
Product-family profile42%
Product ecosystem profile11%
175 inherited, 1 deviated by approved exception, 174 effective.

Resolution order

  1. Core PSLF baselineFR-2026.1+148 obligations

    Nine phases, gates G0-G8, canonical registry, core obligations, risk method v1.2

    Core framework release FR-2026.1 · owner Framework Governance Board

  2. Market profileMP-US-FDA+14 obligations

    Premarket submission evidence set, SBOM expectations, labeling and disclosure obligations

    United States market profile (FDA) · owner Regulatory Intelligence

  3. Customer profileCFP-0001+8 obligations

    ADD-0001 pentest cadence, ADD-0002 Clinical Safety G6 approver, customer evidence templates

    Meridian Medical Systems customer profile · owner Ravi Patel (Customer Framework Administrator)

  4. Product-family profilePFAM-INF-01+4 obligations

    Dosing-integrity control baseline, pump-specific misuse cases, clinical-workflow validation set

    Infusion systems product family · owner Dana Whitfield (Product Owner)

  5. Product ecosystem profilePFP-2026-0042+1 obligation

    Instantiated phase tasks, deliverable identifiers, gate dates, role assignments

    NimbusPump NP-200 ecosystem profile · owner Dana Whitfield + Marcus Chen

  6. Approved exceptionsEXC-0009-1 obligation (deviated)

    OBL-0043 deviated for hardware rev A with compensating controls; expires 31 Dec 2026

    Time-bound exception EXC-0009 (hardware root of trust) · owner Dr. Lena Fischer (Risk Acceptance Authority)

Effective result

Resolved profile
PFP-2026-0042
Product ecosystem
NimbusPump NP-200 Program (PRJ-2026-0042)
Resolved against
FR-2026.1
Resolved at
06 Mar 2026, 14:05 UTC
Market profiles
MP-US-FDA (United States, FDA) · MP-EU-MDR (European Union, MDR)
Administrator
Ravi Patel · Customer Framework Administrator

Profile additions (2)

Independent penetration test each major release

ADD-0001Gate rigorPSLF-04 / G4Approved

Clinical Safety co-approval at release for dosing products

ADD-0002Added approverPSLF-06 / G6Approved

ExceptionEXC-0009Activeresidual MediumExpires 31 Dec 2026

Deviates from for PRJ-2026-0042 — NimbusPump NP-200, hardware revision A only.

  1. Requested (passed)
  2. Under review (passed)
  3. Approved (passed)
  4. Active (current)
  5. Expiring (pending)
  6. Closed (pending)
Requested by
Priya Raman · Security Architect
Approver
Dr. Lena Fischer · Risk Acceptance Authority
Effective from
06 Mar 2026
Review cadence
Quarterly review; re-evaluation on any related vulnerability signal